Business Wire | May 24, 2021 08:00AM EDT

Horizon Therapeutics plc to Participate in Upcoming Investor Conferences

May 24, 2021

DUBLIN--(BUSINESS WIRE)--May 24, 2021--Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following upcoming conferences:

Jefferies Virtual Health Care Conference

* Date: Thursday, June 3, 2021 * Presentation Time: 1 p.m. ET

BMO Biopharma Day: Spotlight on Rare Disease and Ophthalmology

* Date: Tuesday, June 22, 2021 * Presentation Time: 10 a.m. ET

The conference presentations will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizontherapeutics.com. A replay of the webcasts will be available following the events.

About Horizon

Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210524005255/en/

CONTACT: Investors: Tina Ventura Senior Vice President, Investor Relations investor-relations@horizontherapeutics.com

CONTACT: Ruth Venning Executive Director, Investor Relations investor-relations@horizontherapeutics.com

CONTACT: U.S. Media: Geoff Curtis Executive Vice President, Corporate Affairs & Chief Communications Officer media@horizontherapeutics.com

CONTACT: Ireland Media: Ray Gordon Gordon MRM ray@gordonmrm.ie